Outcome of transsphenoidal surgery for Cushing's Disease: a single-center experience over 20 years.

Brichard, Camille;Costa, Emmanuel;Fomekong, Edward;Maiter, Dominique;Raftopoulos, Christian
(2018) World Neurosurgery — Vol. 119, p. e106-e117 (2018)

Files

document.pdf
  • Restricted Access
  • Adobe PDF
  • 895.3 KB

Details

Authors
Abstract
This study investigated the outcome of transsphenoidal surgery for Cushing's disease and the influence of our surgical strategy on remission rates and postoperative pituitary function. We retrospectively reviewed data from 71 patients with CD who underwent TSS in Saint-Luc Hospital between 1996 and 2017. True remission was defined as normal fasting cortisol level, normal 24H urinary free cortisol or continued need for hydrocortisone replacement for one year after surgery. Overall remission rate after one or repeated TSS was 83%. Highest remission rate was found in patients with macroadenomas (92%). Successful first TSS was correlated with a high final remission rate (95%) while failed first TSS was correlated with a low final remission rate (36%). Although Day 1 cortisol levels were significantly lower in patients with long term remission, high levels were still observed in a few patients, especially those suffering from CD for many years. We found a low rate of postoperative pituitary long-term hypofunction (9%). TSS is a safe and effective procedure to treat CD allowing remission rates of 83%. One-year remission period after first surgery is correlated with a final remission rate of 95%. Although Day 1 morning cortisol value is the most significant predictor for long-term remission, some patients with CD for many years may keep high postoperative cortisol levels and be in later remission, likely due to secondary adrenal hyperplasia. Our minimally invasive approach resulted in low rates of postoperative pituitary hypofunction, while keeping a recurrence rate comparable to literature.
Affiliations

Citations

Brichard, C., Costa, E., Fomekong, E., Maiter, D., & Raftopoulos, C. (2018). Outcome of transsphenoidal surgery for Cushing’s Disease: a single-center experience over 20 years. World Neurosurgery, 119, e106-e117. https://doi.org/10.1016/j.wneu.2018.07.055 (Original work published 2018)